Bringing Multiplexed Immunofluorescence & Spatial Biology to The Clinic to Improve Patient Care
Time: 1:45 pm
day: Day 3 Track C
Details:
- Multiplex Immunofluorescence (mIF) and spatial biology biomarkers have demonstrated potential clinical utility in a multitude of translational studies
- Akoya is building a framework to build clinical tests with these biomarkers on our proprietary mIF platform
- Utilizing this framework, we are currently developing impactful tests like the OncoSignature and Immunoprint to improve patient care